Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021	Mar. 31, 2021
ASSETS
Cash and cash equivalents	$ 8,431	$ 8,195
Restricted cash and cash equivalents	2,372	1,957
Investments in marketable securities	5,121	4,820
Finance receivables, net of allowance for credit losses of $1,185 and $1,178	80,925	79,192
Investments in operating leases, net	36,836	37,091
Other assets	2,450	2,473
Total assets	136,135	133,728
LIABILITIES AND SHAREHOLDER’S EQUITY
Debt	110,122	109,725
Deferred income taxes	2,399	2,860
Other liabilities	5,725	5,548
Total liabilities	118,246	118,133
Commitments and contingencies (Refer to Note 9)
Shareholder’s equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at December 31, 2021 and March 31, 2021	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive income	11	8
Retained earnings	16,961	14,670
Total shareholder's equity	17,889	15,595
Total liabilities and shareholder's equity	$ 136,135	$ 133,728